We have previously shown that estrogen withdrawal by gonadotrophin-rel
easing hormone analogs (GnRHa) induces osteocyte death via apoptosis i
n human bone. Although it is likely that the increase in osteocyte dea
th via apoptosis was related to the loss of estrogen, these experiment
s could not rule out a direct role for the GnRHa. Therefore, in this s
tudy, we have used a rat model of ovariectomy (OVX) to determine wheth
er the effect of estrogen withdrawal extends to other species and to c
larify the role of estrogen in the maintenance of osteocyte viability.
Twelve 9-week-old rats were divided into three treatment groups: sham
operated (SHAM) (n = 4), OVX (n = 4), and OVX + estrogen (E2) (25 mu
g/day) (n = 4). At 3 weeks following the start of treatment, tibial bo
nes were removed. The percentage of osteocytes displaying DNA breaks,
using an in situ nick-translation method, was significantly higher in
the OVX group compared with the SHAM control in both cortical bone (10
.04% vs. 2.31%, respectively; p < 0.0001) and trabecular bone (6.44% v
s. 1.58%, respectively; p = 0.003). Addition of estrogen in the OVX an
imals completely abrogated the increase in osteocyte apoptosis in cort
ical bone (0.78%) and trabecular bone (1.17%). The percentage of apopt
otic osteocytes decreased with increasing distance from the primary/se
condary spongiosa interface below the growth plate in the OVX model an
d the OVX + E2 model. Nuclear morphology and electrophoresis of DNA co
nfirmed the presence of apoptotic cells in the samples. In conclusion,
OVX in the rat results in an increase in osteocyte apoptosis as a dir
ect or indirect result of E2 loss. Addition of estrogen in the OVX ani
mals prevents this increase in osteocyte apoptosis. These data confirm
an important role for estrogen in the control of osteocyte apoptosis
and the maintenance of osteocyte viability. Estrogen deficiency might,
through compromising the viability of osteocyte networks, reduce the
ability of bone to respond appropriately to loading.